Wu Tsai Human Performance Alliance
Showing 1-20 of 219 Results
-
Oliver O. Aalami, MD
Clinical Professor, Surgery - Vascular Surgery
Current Research and Scholarly InterestsWe launched a national precision medicine PAD trial called, VascTrac (http://vasctrac.stanford.edu/). This trial is mobile phone based and leverages Apple's ResearchKit Platform to monitor a patient's activity both pre- and post-intervention. We are validating mobile phone surveillance for PAD patients and are currently enrolling.
-
Geoffrey Abrams, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Abrams' research is focused on elucidating the pathobiology behind tendinoapthy and developing new treatment modalities for the disease. Specifically, his team is studying the role of micro-RNA as it relates to chronic inflammation and stem cell differentiation in the development and perpetuation of chronic tendinopathy.
-
Ehsan Adeli
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsMy research lies in the intersection of Machine Learning, Computer Vision, Healthcare, and Computational Neuroscience.
-
Tayyeba K. Ali, MD
Adjunct Clinical Associate Professor, Ophthalmology
BioTayyeba K. Ali, MD, a Board Certified ophthalmologist, specializes in complex corneal disease and uveitis. She sees patients at Palo Alto Medical Foundation / Sutter Health in Sunnyvale, CA. Dr. Ali also works as a medical specialist on contract for Google.
Prior to completing two fellowships in cornea, external disease, refractive surgery and uveitis at Bascom Palmer Eye Institute, ranked #1 eye hospital in the United States by U.S. News & World Report, Dr. Ali finished her ophthalmology residency at the Jones Eye Institute / UAMS. She earned her medical degree from Emory University School of Medicine and completed her undergraduate training in English literature and creative writing from Agnes Scott College.
Dr. Ali has received many academic and teaching awards including the Bascom Palmer Fellow of the Year Award and the Jone’s Eye Dean’s Faculty Award. She has delivered dozens of lectures on the national and international level and published numerous meeting abstracts and peer-reviewed journal articles.
As a second generation American, Tayyeba finds herself dwelling on migrant and refugee stories, their need for ethnic and religious identity, and the repercussions of these journeys. She is keenly interested in international medicine, resident education, health technology and taking a closer look at the moral crossroads we face in healthcare. She is the Associated Director for Pegasus Physician Writers at Stanford as well as the Senior Fiction Editor for the medical literary magazine, The Pegasus Review; she has a particular affinity for colons (grammatically, not anatomically, speaking) and semicolons. -
Russ B. Altman
Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine (General Medical Discipline), of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsI refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/
-
Al'ai Alvarez, MD, FACEP, FAAEM
Clinical Associate Professor, Emergency Medicine
BioAl’ai Alvarez, MD FACEP FAAEM (@alvarezzzy) is a national leader and educator on wellness, diversity, equity, and inclusion. He is an emergency physician and clinical associate professor of Emergency Medicine (EM) at Stanford University. Dr. Alvarez is the Director of Well-Being and co-chair of the Human Potential Team at Stanford Emergency Medicine. He also serves as the Director of the first Physician Wellness Fellowship. His work focuses on humanizing physician roles as individuals and teams by harnessing the individual human potential in the context of high-performance teams. His long-term interest is to optimize the interconnectedness between Medical Education, Process Improvement (Quality and Clinical Operations), Recruitment (Diversity), and Well-being (Inclusion) through human-centered design.
Dr. Alvarez is the chair of Stanford WellMD’s Physician Wellness Forum and the director of Stanford’s peer-to-peer support for faculty and trainees, the Physician Resource Network (PRN) Support Program.
Dr. Alvarez is a faculty fellow at the Stanford Byers Center for Biodesign (2021-2022), exploring the role of mindfulness in high-stress environments. He is also the co-director and organizer for the High-Performance Resuscitation Teams Summit (https://bit.ly/HPRT2023) in collaboration with Mayo Clinic and the Mission Critical Teams Institute. HPRT aims to develop a collaborative inquiry among teams from various disciplines, including healthcare, aerospace, sports, military, special operations forces, fire rescue, and other high-performing/elite teams.
Dr. Alvarez was the associate residency program director (APD) at the Stanford Emergency Medicine Residency Program [2016-2021]. Among his roles, he served as the second-year class APD and the Medicine Without Walls (MWOW) Line Director for the Stanford Emergency Medicine ACCEL Program (https://emed.stanford.edu/residency/ACCEL.html).
Nationally, Dr. Alvarez serves on committees on physician well-being and diversity, equity, and inclusion in medical education. He is the co-chair of the Council of EM Residency Directors (CORD) Wellness Leadership Mini-Fellowship, a mentor at the Academic Life in Emergency Medicine (ALiEM) Faculty Incubator, and co-founded and co-chair of the largest national diversity mentoring program in EM through the joint American College of Emergency Physician (ACEP) ’s Diversity, Inclusion and Health Equity (DIHE) and the Emergency Medicine Residents Association (EMRA) ’s Diversity Mentorship Initiative.
Dr. Alvarez has given numerous grand rounds and national and international conference lectures and workshops on relevant topics that humanize physicians (#doctorsarehumanstoo), the importance of self-compassion and belonging in physician well-being, and efforts to advance diversity, equity, and inclusion in medicine.
Dr. Alvarez received the 2019 ACEP DIHE Distance and Impact Award, the 2020 Society for Academic Emergency Medicine (SAEM) Academy for Diversity and Inclusion in Emergency Medicine (ADIEM) Outstanding Academician Award, the 2020 CORD Academy for Scholarship in Education in EM Academy Member Award on Teaching and Evaluation, and the 2022 John Levin Leadership Award at Stanford Health Care. -
Eric Appel
Associate Professor of Materials Science and Engineering and, by courtesy, of Pediatrics (Endocrinology)
Current Research and Scholarly InterestsThe underlying theme of the Appel Lab at Stanford University integrates concepts and approaches from supramolecular chemistry, natural/synthetic materials, and biology. We aim to develop supramolecular biomaterials that exploit a diverse design toolbox and take advantage of the beautiful synergism between physical properties, aesthetics, and low energy consumption typical of natural systems. Our vision is to use these materials to solve fundamental biological questions and to engineer advanced healthcare solutions.
-
Euan A. Ashley
Associate Dean, School of Medicine, Roger and Joelle Burnell Professor of Genomics and Precision Health, Professor of Medicine (Cardiovascular Medicine), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology
Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.
-
Themistocles (Tim) Assimes
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
-
Stephen A. Baccus
Professor of Neurobiology
Current Research and Scholarly InterestsWe study how the neural circuitry of the vertebrate retina encodes visual information and performs computations. To control and measure the retinal circuit, we present visual images while performing simultaneous two-photon imaging and multielectrode recording. We perturb the circuit as it operates using simultaneous intracellular current injection and multielectrode recording, and use the resulting large data sets to construct models of retinal computation.
-
Fred M Baik, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Baik is Assistant Professor of Otolaryngology – Head & Neck Surgery at Stanford University. He provides comprehensive surgical care for patients with head and neck cancer, both as an ablative and reconstructive surgeon. His clinical interests include oral cavity cancer, complex skin cancer, microvascular reconstruction and the diagnosis and management of nodal metastasis. With his background in fluorescence imaging, Dr. Baik’s research focuses on surgical navigation using targeted agents to improve tumor margin assessment and the detection of nodal metastasis, and he currently leads several clinical trials to translate novel imaging techniques.
Dr. Baik graduated with honors in Biology at the University of Pennsylvania and received his medical degree at UC San Diego. After completing his Otolaryngology residency at the University of Washington, he pursued advanced training in Head and Neck Oncology & Reconstructive Surgery at Mount Sinai Beth Israel Hospital in New York City. He is a board-certified by the American Board of Otolaryngology, and a member of the American Head and Neck Society, American Academy of Otolaryngology – Head and Neck Surgery, and a fellow of the American College of Surgeons. -
Jeremy Bailenson
Thomas More Storke Professor, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Education
BioJeremy Bailenson is founding director of Stanford University’s Virtual Human Interaction Lab, Thomas More Storke Professor in the Department of Communication, Professor (by courtesy) of Education, Professor (by courtesy) Program in Symbolic Systems, and a Senior Fellow at the Woods Institute for the Environment. He has served as Director of Graduate Studies in the Department of Communication for over a decade. He earned a B.A. from the University of Michigan in 1994 and a Ph.D. in cognitive psychology from Northwestern University in 1999. He spent four years at the University of California, Santa Barbara as a Post-Doctoral Fellow and then an Assistant Research Professor.
Bailenson studies the psychology of Virtual and Augmented Reality, in particular how virtual experiences lead to changes in perceptions of self and others. His lab builds and studies systems that allow people to meet in virtual space, and explores the changes in the nature of social interaction. His most recent research focuses on how virtual experiences can transform education, environmental conservation, empathy, and health. He is the recipient of the Dean’s Award for Distinguished Teaching at Stanford. In 2020, IEEE recognized his work with “The Virtual/Augmented Reality Technical Achievement Award”.
He has published more than 200 academic papers, spanning the fields of communication, computer science, education, environmental science, law, linguistics, marketing, medicine, political science, and psychology. His work has been continuously funded by the National Science Foundation for over 25 years.
His first book Infinite Reality, co-authored with Jim Blascovich, emerged as an Amazon Best-seller eight years after its initial publication, and was quoted by the U.S. Supreme Court. His new book, Experience on Demand, was reviewed by The New York Times, The Wall Street Journal, The Washington Post, Nature, and The Times of London, and was an Amazon Best-seller.
He has written opinion pieces for The Washington Post, The Wall Street Journal, Harvard Business Review, CNN, PBS NewsHour, Wired, National Geographic, Slate, The San Francisco Chronicle, TechCrunch, and The Chronicle of Higher Education, and has produced or directed six Virtual Reality documentary experiences which were official selections at the Tribeca Film Festival. His lab has exhibited VR in hundreds of venues ranging from The Smithsonian to The Superbowl. -
Steven Banik
Assistant Professor of Chemistry
BioSteven Banik’s research interests center on rewiring mammalian biology and chemical biotechnology development using molecular design and construction. Projects in the Banik lab combine chemical biology, organic chemistry, protein engineering, cell and molecular biology to precisely manipulate the biological machines present in mammalian cells. Projects broadly aim to perform new functions that shed light on regulatory machinery and the potential scope of mammalian biology. A particular focus is the study of biological mechanisms that can be coopted by synthetic molecules (both small molecules and proteins). These concepts are applied to develop new therapeutic strategies for treating aging-related disorders, genetic diseases, and cancer.
Prior to joining the faculty at Stanford, Steven was a NIH and Burroughs CASI postdoctoral fellow advised by Prof. Carolyn Bertozzi at Stanford. His postdoctoral research developed approaches for targeted protein degradation from the extracellular space with lysosome targeting chimeras (LYTACs). He received his Ph.D. from Harvard University in 2016, where he worked with Prof. Eric Jacobsen on synthetic methods for the selective, catalytic difluorination of organic molecules and new approaches for generating and controlling reactive cationic intermediates in asymmetric catalysis. -
Zhenan Bao
K. K. Lee Professor and Professor, by courtesy, of Materials Science and Engineering and of Chemistry
On Partial Leave from 04/01/2023 To 06/30/2023BioZhenan Bao joined Stanford University in 2004. She is currently a K.K. Lee Professor in Chemical Engineering, and with courtesy appointments in Chemistry and Material Science and Engineering. She was the Department Chair of Chemical Engineering from 2018-2022. She founded the Stanford Wearable Electronics Initiative (eWEAR) and is the current faculty director. She is also an affiliated faculty member of Precourt Institute, Woods Institute, ChEM-H and Bio-X. Professor Bao received her Ph.D. degree in Chemistry from The University of Chicago in 1995 and joined the Materials Research Department of Bell Labs, Lucent Technologies. She became a Distinguished Member of Technical Staff in 2001. Professor Bao currently has close to 700 refereed publications and more than 80 US patents with a Google Scholar H-index 201.
Bao is a member of the US National Academy of Engineering, the American Academy of Arts and Sciences and the National Academy of Inventors. Bao was elected a foreign member of the Chinese Academy of Science in 2021. She is a Fellow of AAAS, ACS, MRS, SPIE, ACS POLY and ACS PMSE.
Bao is a member of the Board of Directors for the Camille and Dreyfus Foundation from 2022. She served as a member of Executive Board of Directors for the Materials Research Society and Executive Committee Member for the Polymer Materials Science and Engineering division of the American Chemical Society. She was an Associate Editor for the Royal Society of Chemistry journal Chemical Science, Polymer Reviews and Synthetic Metals. She serves on the international advisory board for Advanced Materials, Advanced Energy Materials, ACS Nano, Accounts of Chemical Reviews, Advanced Functional Materials, Chemistry of Materials, Chemical Communications, Journal of American Chemical Society, Nature Asian Materials, Materials Horizon and Materials Today. She is one of the Founders and currently sits on the Board of Directors of C3 Nano Co. and PyrAmes, both are silicon valley venture funded companies.
Bao was a recipient of the VinFuture Prize Female Innovator 2022, ACS Award of Chemistry of Materials 2022, MRS Mid-Career Award in 2021, AICHE Alpha Chi Sigma Award 2021, ACS Central Science Disruptor and Innovator Prize in 2020, ACS Gibbs Medal in 2020, the Wilhelm Exner Medal from the Austrian Federal Minister of Science in 2018, the L'Oreal UNESCO Women in Science Award North America Laureate in 2017. She was awarded the ACS Applied Polymer Science Award in 2017, ACS Creative Polymer Chemistry Award in 2013 ACS Cope Scholar Award in 2011. She is a recipient of the Royal Society of Chemistry Beilby Medal and Prize in 2009, IUPAC Creativity in Applied Polymer Science Prize in 2008, American Chemical Society Team Innovation Award 2001, R&D 100 Award, and R&D Magazine Editors Choice Best of the Best new technology for 2001. -
Annelise E. Barron
Associate Professor of Bioengineering
Current Research and Scholarly InterestsBiophysical mechanisms of host defense peptides (a.k.a. antimicrobial peptides) and their peptoid mimics; also, molecular and cellular biophysics of human innate immune responses.
-
Carolyn Bertozzi
Baker Family Director of Stanford ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology
BioProfessor Carolyn Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface sugars important to human health and disease. Her research group profiles changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and uses this information to develop new diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.
Dr. Bertozzi completed her undergraduate degree in Chemistry at Harvard University and her Ph.D. at UC Berkeley, focusing on the chemical synthesis of oligosaccharide analogs. During postdoctoral work at UC San Francisco, she studied the activity of endothelial oligosaccharides in promoting cell adhesion at sites of inflammation. She joined the UC Berkeley faculty in 1996. A Howard Hughes Medical Institute Investigator since 2000, she came to Stanford University in June 2015, among the first faculty to join the interdisciplinary institute ChEM-H (Chemistry, Engineering & Medicine for Human Health). She is now the Baker Family Director of Stanford ChEM-H.
Named a MacArthur Fellow in 1999, Dr. Bertozzi has received many awards for her dedication to chemistry, and to training a new generation of scientists fluent in both chemistry and biology. She has been elected to the Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences; and received the Lemelson-MIT Prize, the Heinrich Wieland Prize, the ACS Award in Pure Chemistry, and the Chemistry of the Future Solvay Prize, among others.
The Bertozzi Group develops chemical tools to study the glycobiology underlying diseases such as cancer, inflammation, tuberculosis and most recently COVID-19. She is the inventor of "bioorthogonal chemistry", a class of chemical reactions compatible with living systems that enable molecular imaging and drug targeting. Her group also developed new therapeutic modalities for targeted degradation of extracellular biomolecules, such as antibody-enzyme conjugates and Lysosome Targeting Chimeras (LYTACs). As well, her group studies NGly1 deficiency, a rare genetic disease characterized by loss of the human N-glycanase.
Several of the technologies developed in the Bertozzi lab have been adapted for commercial use. Actively engaged with several biotechnology start-ups, Dr. Bertozzi cofounded Redwood Bioscience, Enable Biosciences, Palleon Pharmaceuticals, InterVenn Bio, OliLux Bio, Grace Science LLC and Lycia Therapeutics. She is also a member of the Board of Directors of Lilly. -
Achintya K. Bhowmik, PhD
Adjunct Professor, OHNS/Otology & Neurotology Division
BioDr. Achin Bhowmik serves on the faculty of Stanford University as an adjunct professor at the Stanford School of Medicine, where he advises research and lectures in the areas of sensory augmentation, computational perception, cognitive neuroscience, and intelligent systems. He is also an affiliate faculty member of the Stanford Institute for Human-Centered Artificial Intelligence, Wu Tsai Neurosciences Institute and Human Performance Alliance, and a mentor for the Stanford Institutes of Medicine Summer Research Program.
He is the chief technology officer and executive vice president of engineering at Starkey Hearing Technologies, a privately-held medical devices company with over 5,000 employees and operations in over 100 countries worldwide. In this role, he is responsible for the company’s technology strategy, research and development, engineering and program management departments, and leading the drive to transform hearing aids into multifunction wearable health and communication devices with advanced sensors and artificial intelligence.
Previously, Dr. Bhowmik was the vice president and general manager of the Perceptual Computing Group at Intel Corporation, where he was responsible for the R&D, engineering, operations, and businesses in the areas of 3D sensing and interactive computing, computer vision and artificial intelligence, autonomous robots and drones, and immersive virtual and merged reality devices.
Dr. Bhowmik is a member of the Forbes Technology Council, board of trustees for the National Captioning Institute, board of directors for OpenCV, board of advisors for the Fung Institute for Engineering Leadership at the University of California, Berkeley, and industry advisory board for the Institute for Engineering in Medicine and Biomedical Engineering at the University of Minnesota. He is also on the board of directors and advisors for several technology startup companies.
He has also held adjunct and guest professor positions at the University of California, Berkeley, Liquid Crystal Institute of the Kent State University, Kyung Hee University, Seoul, and the Indian Institute of Technology, Gandhinagar. He received his Bachelor of Technology from the Indian Institute of Technology, Kanpur, PhD from Auburn University, and attended the Executive Program at Stanford University. He has authored over 200 publications, including two books and over 80 granted patents.
His awards and honors include Fellow of the Institute of Electrical and Electronics Engineers (IEEE), Fellow of the Asia-Pacific Artificial Intelligence Association (AAIA), President and Fellow of the Society for Information Display (SID), Top 25 Healthcare Technology CTOs by the Healthcare Technology Report, Notable Leaders in Healthcare by Twin Cities Business, Healthcare Heroes award from the Business Journals, Industrial Distinguished Leader award from the Asia-Pacific Signal and Information Processing Association, IEEE Distinguished Industry Speaker, TIME’s Best Inventions, Red Dot Design award, MUSE Design award, and the Artificial Intelligence Excellence award.
Dr. Bhowmik and his work have been covered in numerous press articles, including TIME, Fortune, Wired, USA Today, US News & World Reports, Wall Street Journal, CBS News, BBC, Forbes, Bloomberg Businessweek, Scientific American, Popular Mechanics, MIT Technology Review, EE Times, The Verge, etc. -
Nidhi Bhutani
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsThe long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.
-
Sarah Billington
UPS Foundation Professor and Senior Fellow at the Woods Institute for the Environment
BioOur group studies the impact of building design, materials, and symbols on human wellbeing including stress, physical activity, creativity, sense of belonging, and pro-environmental behavior. We are exploring how buildings can include both physical and digital adaptations to improve wellbeing outcomes including new methods of bringing nature and the experience of nature into buildings. We are interested in how building management systems can be extended beyond providing energy savings, thermal comfort, and security to support and maintain a broader set of human wellbeing outcomes while preserving occupant privacy. Further, we are studying the impact of built features, including historic structures, on community wellbeing and methods of design for community wellbeing that support the equitable development of affordable and permanent supportive housing.
Our group also has a long history of expertise in the design and evaluation of sustainable, durable construction materials, their application to structures and construction, including damage-tolerant, high-performance fiber-reinforced cementitious composite materials, and bio-based fiber-reinforced polymeric composites and insulating foams that have a closed loop life-cycle.
